Autolus Therapeutics AUTL
NASDAQ AUTL
$2.24 -0.05 (-2.18%)
As of: Sep 4, 2026 · 3:59 PM EDT

Autolus Therapeutics (AUTL) Market Capitalization (2018 - 2026)

Analysis

Autolus Therapeutics (AUTL) Market Capitalization (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Autolus Therapeutics 594.86 Mn 393.23 Mn 25.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 568.07 Mn
Dec 31, 2025 706.52 Mn
Sep 30, 2025 578.71 Mn
Jun 30, 2025 809.47 Mn
Mar 31, 2025 550.36 Mn
Dec 31, 2024 834.37 Mn
Sep 30, 2024 1.29 Bn
Jun 30, 2024 1.24 Bn
Mar 31, 2024 2.26 Bn
Dec 31, 2023 1.69 Bn
Sep 30, 2023 612.47 Mn
Jun 30, 2023 625.01 Mn
Mar 31, 2023 482.08 Mn
Dec 31, 2022 497.80 Mn
Sep 30, 2022 385.33 Mn
Jun 30, 2022 508.94 Mn
Mar 31, 2022 749.92 Mn
Dec 31, 2021 933.35 Mn
Sep 30, 2021 925.35 Mn
Jun 30, 2021 938.06 Mn